Skip to Main Content

Author Details

Afam A Okoye
Vaccine & Gene Therapy Institute, and Oregon National Primate Research Center
2003
24
14
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37801446Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication.PLoS Pathog2023
35041707The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription.PLoS Pathog2022
36162961Effects of Early Antiretroviral Therapy on the Composition and Diversity of the Fecal Microbiome of SIV-infected Rhesus Macaques (<i>Macaca mulatta</i>).Comp Med2022
35316218Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.J Clin Invest2022
34485613Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques.Mol Ther Methods Clin Dev2021
33536176Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>.J Virol2021
33630764CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.J Clin Invest2021
32988211Real-Time Killing Assays to Assess the Potency of a New Anti-Simian Immunodeficiency Virus Chimeric Antigen Receptor T Cell.AIDS Res Hum Retroviruses2020
30430748Lymph nodes as barriers to T-cell rejuvenation in aging mice and nonhuman primates.Aging Cell2019
31653683Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques.J Immunol2019
31295427The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections.Cell Host Microbe2019
31597757<i>In Vivo</i> Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency Viruses.J Virol2019
29135580Wake me up before you go: a strategy to reduce the latent HIV reservoir.AIDS2018
30082858Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.Nat Med2018
28514279Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.AIDS2017
27430715Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques.J Immunol2016
25599132B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.Nat Med2015
26416281Effect of IL-7 Therapy on Naive and Memory T Cell Homeostasis in Aged Rhesus Macaques.J Immunol2015
23772614CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.Immunol Rev2013
22451717Naive T cells are dispensable for memory CD4+ T cell homeostasis in progressive simian immunodeficiency virus infection.J Exp Med2012
20622118Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.J Immunol2010
19546246Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis.J Exp Med2009
17724130Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection.J Exp Med2007
12732629A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis.J Biol Chem2003
  • 1 - 24 of 24

Recommended Authors

Alyssa R Martin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2015
Number of shared co-authors 7
Blake Frey
University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Xiaoyu Luo
Gladstone Institutes, University of California san francisco
Career Start Year 2014
Number of shared co-authors 13
Jocelyn T Kim
University of California Los Angeles
Career Start Year 2011
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 4
Amy L Ellis-Connell
University of Wisconsin
Career Start Year 2010
Number of shared co-authors 0
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 1
Claudia T Flynn
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Kristina De Paris
University of North Carolina at Chapel Hill Chapel Hill
Career Start Year 2004
Number of shared co-authors 2
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 0
Sheila M Keating
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 6
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 5
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 0
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 3
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 2
Mary E Moreno
San Francisco General Hospital, University of California
Career Start Year 1996
Number of shared co-authors 2
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 2
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 9
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 2
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 7
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 6
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 7
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 11
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 5
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 6
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 12
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 3
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 3
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 5

Collaborators

Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 18
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 13
Byung Park
Oregon Health & Science University
Co-authored papers 5
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 5
Benjamin Varco-Merth
Vaccine and Gene Therapy Institute and.
Co-authored papers 5
Brandon F Keele
Co-authored papers 3
Michael Nekorchuk
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 2
Janko Nikolich-Zugich
University of Arizona Center on Aging, University of Arizona
Co-authored papers 2
Timothy J Henrich
University of California san francisco
Co-authored papers 2
Francois Villinger
Co-authored papers 2
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 1
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Zachary W Grimmett
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Andrea Gramatica
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 1
Michael Snape
AMO Pharma Ltd.
Co-authored papers 1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Co-authored papers 1
Mauricio Montano
Gladstone Institutes
Co-authored papers 1
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Co-authored papers 1
Hannah S Sperber
Institute for Translational HIV Research, University Hospital Essen
Co-authored papers 1
Daniel Rosenthal
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Louise E Hogan
University of California San Francisco
Co-authored papers 1
Warner C Greene
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 1
Emilie Besnard
Gladstone Institute of Virology, Gladstone Institutes
Co-authored papers 1
Stephen A Migueles
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Thomas A Packard
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Jason M Brenchley
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Roland Schwarzer
University Hospital Essen, Institute for Translational HIV Research
Co-authored papers 1
Eytan Herzig
J. David Gladstone Institutesgrid.249878.8
Co-authored papers 1
Release 1.2